Cost effectiveness of managing individuals at high riskof melanoma in a High Risk Clinic compared withstandard care       ...
BackgroundMelanoma in high risk groups› Cutaneous melanoma is the 4th most common cancer in men and women in  Australia› C...
Study AimsPrimary and secondary aims› The primary aim of the study is to determine if it is cost effective from the  persp...
MethodsStudy design and data sources› Modeled economic evaluation utilising mostly retrospective data› Intervention group›...
CHeReL linkage diagram                      All people in 45 and                            Up Study                      ...
OutcomesPrimary and secondary outcomes› Calculate the ICER (incremental cost effective ratio) of the two alternative  mode...
Decision tree for melanoma surveillance                                          7
Markov diagram for melanoma health states                                     New primary                                 ...
Significance and future directions› Prospective data collection to measure quality of life› Currently establishing 3 addit...
AcknowledgementsSupervisors› Dr Anne Cust› Dr Rachael Morton› Professor Graham Mann› Professor Scott MenziesPhD scholarshi...
Upcoming SlideShare
Loading in …5
×

Caroline Watts | Cost effectiveness of managing individuals at high risk of melanoma in a High Risk Clinic compared with standard care

936 views

Published on

Caroline Watts gave an update on her research using the 45 and Up Study data at our 2012 Annual 45 and Up Study Collaborators' Meeting.

This meeting is an annual event that offers our research partners, supporters and other interested parties the opportunity to receive a comprehensive update on the 45 and Up Study’s progress and updates on research projects that are using the Study resource. The meeting is also an opportunity for researchers, health decision makers and evaluators to engage and discuss the potential for maximising the Study’s value.

For more information, visit www.saxinstitute.org.au

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
936
On SlideShare
0
From Embeds
0
Number of Embeds
207
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Caroline Watts | Cost effectiveness of managing individuals at high risk of melanoma in a High Risk Clinic compared with standard care

  1. 1. Cost effectiveness of managing individuals at high riskof melanoma in a High Risk Clinic compared withstandard care Caroline Watts Cancer Epidemiology and Services Research Group Sydney School of Public Health
  2. 2. BackgroundMelanoma in high risk groups› Cutaneous melanoma is the 4th most common cancer in men and women in Australia› Certain groups are at higher risk of melanoma than the general population› Early detection is a major determinant of survival and rationale for screening› Opportunist and regular screening of high risk groups is effective in detecting melanomas at an early stage› A High Risk Clinic was established at Royal Prince Alfred Hospital in 2006 with the aim of improving the management of individuals at high risk of melanoma 2
  3. 3. Study AimsPrimary and secondary aims› The primary aim of the study is to determine if it is cost effective from the perspective of the Australian health care system to manage individuals at high risk of melanoma in a specialised high risk clinic compared with the standard› The secondary aim is to examine this question from the societal perspective 3
  4. 4. MethodsStudy design and data sources› Modeled economic evaluation utilising mostly retrospective data› Intervention group› High Risk Clinic› Standard Care group› MPOC study› 45 and Up study 4
  5. 5. CHeReL linkage diagram All people in 45 and Up Study Sax CHeReL Institute› 45 and Up NSW CCR- confirmed MBS data set melanomaStudy cohort NSW APDC 5
  6. 6. OutcomesPrimary and secondary outcomes› Calculate the ICER (incremental cost effective ratio) of the two alternative models of care› - health system perspective› - societal perspective› Calculate ICER at 1,10 years and 20 years› Calculate the ICER per quality adjusted life year› Calculate the ICER per excision avoided› Calculate the ICER per melanoma detected› Calculate the ICER per life years saved 6
  7. 7. Decision tree for melanoma surveillance 7
  8. 8. Markov diagram for melanoma health states New primary lesion; invasive melanoma High risk Diagnosedindividual with Melanoma free melanoma and suspicious New primary excision lesion lesion; in-situ melanoma Local /regional metastatic disease Death – other causes Distant Death - metastatic melanoma disease
  9. 9. Significance and future directions› Prospective data collection to measure quality of life› Currently establishing 3 additional high risk clinics in NSW› Relevance to health policy in NSW and Australia 9
  10. 10. AcknowledgementsSupervisors› Dr Anne Cust› Dr Rachael Morton› Professor Graham Mann› Professor Scott MenziesPhD scholarship funded by a CINSW fellowship to Dr Anne CustSydney Catalyst Top-Up Research Scholar Award 10

×